Villabeto, Analiza F.
HRN: 17-93-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2025
CEFUROXIME 500MG (TAB)
07/11/2025
07/17/2025
ORAL
500mg
Q12
NSVD With RMLE
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes